Proprotein Convertase Subtilisin / Kexin Type 9 (PCSK9) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. - Woźniak, Ewelina; Woźniak, Agnieszka; Pawlos, Agnieszka; Broncel, Marlena; Satała, Joanna; Bukowska, Bożena; Gorzelak-Pabiś, Paulina (International Journal of Molecular Sciences, 2025)